How lomg doe sthis place have until...

Discussion in 'Shionogi' started by Anonymous, Jun 21, 2014 at 7:52 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    the entire US division folds? NOTHING is selling. We can't sustain this.
     

  2. Anonymous

    Anonymous Guest

    Fox Business news segment said not good. Real soon
     
  3. Anonymous

    Anonymous Guest

    I'm surprised we've lasted this long.
     
  4. Anonymous

    Anonymous Guest

    Surprised we lasted this long, too. Clearly the field force is illiterate.
     
  5. Anonymous

    Anonymous Guest

    The quality of reps isn't that great. Only a small percentage has strong selling skills that are admirable. Plus the drug is targeted to a small population. Too many DMs and too many reps for one drug. It's sad and embarrassing
     
  6. Anonymous

    Anonymous Guest

    Exactly! Overblown sales force!
    Too many RDs...waaaay toooo many DMs; poor reps

    There will be a cleaning up of this house soon. Can't sustain this. They know it too!

    Look what happened in NY district. We all heard that was a shock at HQ and they tried to cover it up. EVERYONE quit pretty much! Poor mgt poor direction all over.
     
  7. Anonymous

    Anonymous Guest

    Not long. No budget. Limited indications. Docs are picking up on Duavee. We are sunk.
     
  8. Anonymous

    Anonymous Guest

    When do you think next lay offs will happen?
     
  9. Anonymous

    Anonymous Guest

    Duavee is NOT picking up, except for samples on shelf.
     
  10. Anonymous

    Anonymous Guest

    Nov - Dec
    includes DMs and an RD
     
  11. Anonymous

    Anonymous Guest

    Then you are NOT paying attention. Ask one of the many Pfizer reps selling the product. They have only been promoting it for two months and the uptake is growing.
     
  12. Anonymous

    Anonymous Guest

    Thank you Pfizer rep.
    In any event what would you expect the rep to say.
     
  13. Anonymous

    Anonymous Guest

    Forget Duavee. Look at the WFR and the national numbers for Osphena. A successful launch would be early significant growth week after week. The first six months if you charted it should have a line going straight up instead of a slow gradual curve. There should be NO weeks where you go backwards in the script numbers in a successful launch. The numbers don't lie. This product will be in the red for years. The question is can Shionogi U.S. sustain this albatross.
     
  14. Anonymous

    Anonymous Guest

    Probably from the same ass clown who insisted the layoffs were "guaranteed" to be March 31
     
  15. Anonymous

    Anonymous Guest

    This drug will be a blockbuster in 3 years if all the pre clinical data holds and we can actually discuss the most asked questions around bone and breast. Until then it's going to remain stagnant
     
  16. Anonymous

    Anonymous Guest

    Bingo. Million dollar question is will the company keep us on until then.
     
  17. Anonymous

    Anonymous Guest

    how the hell everyone left that district is a mind blower. What does that tell ya dude?
     
  18. Anonymous

    Anonymous Guest

    Honey wake the fuck up. The drug works for only a small percentage of women not for everyone. Not every woman cares to take it or actually has painful sex so even if sales were there it won't be a blockbuster but just another drug. I'm not being negative but rather realistic
     
  19. Anonymous

    Anonymous Guest

    It's like being on an overloaded train, going down a mountain, with no captain or brakes.
     
  20. Anonymous

    Anonymous Guest

    (In Sean Connery voice)...."Captain?...Surely you mean engineer my good man"